Study to Evaluate the Safety and clinical efficacy of Augmentin® Extra Strength-600 in Children with Acute Otitis Media in India

Trial Identifier: 213514
Sponsor: GlaxoSmithKline
Collaborator:
IQVIA
Start Date: May 2022
Primary Completion Date: November 2022
Study Completion Date: November 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
India Belgaun, India, 590010
India Hyderabad, India, 500018
India Kanpur, India, 208002
India Kolkata, India, 700017
India Ludhiana, India, 141008
India Madurai, India, 625107
India Nagpur, India, 440009
India New Delhi, India, 110002
India Pune, India, 411043
India Purne, India, 411030
India, Chhattisgarh Raipur, Chhattisgarh, India, 492099
India, Rajasthan Jaipur, Rajasthan, India, 302016
India, Uttar Pradesh Varanasi, Uttar Pradesh, India, 221001